Drug Benefit News

Highlights on this Page

Publication Details

Subscriptions include print and electronic issues

  • Frequency: biweekly (24 issues/year)
  • Pages: 8
  • Format: Print and PDF versions
  • ISSN: 1530-3438

  • Pub Code: NDBNR-11WEB

3 Easy Ways to Order

  1. Secure Shopping Cart
  2. Call 800-521-4323
  3. Print a form to fax or mail

Drug Benefit News

News, Data and Business Strategies for Health Plans, Employers, PBMs and Pharma Companies

A hard-hitting newsletter for health plans, PBMs, pharma companies and employers. Published biweekly, it delivers both timely news stories and in-depth accounts of cost management strategies that are being employed by drug purchasers. Coverage includes up-to-the minute news of industry consolidation, strategies for participation in exchanges, generic promotion tactics, formulary decisions, innovative benefit designs, drug pricing methodologies, PBM contracting, changes in Part D and other federal initiatives, and much more.

Renew Your Subscription Today!

Place your order through our secure shopping cart

24 issues, plus E-Alerts and access to a subscriber-only website
$651.00
48 issues, plus E-Alerts and access to a subscriber-only website
$1,172.00

Make sure you continue receiving timely news and proven strategies for improving outcomes and controlling pharmacy costs.

Potentially explosive changes lie ahead under the Trump administration and Republican Congress, and the stakes involved — for health plans, PBMs, pharma companies and their business partners — are equally enormous.


Renew your subscription and Drug Benefit News will continue to provide you with timely news and analysis … and practical cost management strategies from experts.


With Drug Benefit News, you’ll remain up-to-date on big-dollar topics such as:

  • The impact health insurers and PBMs could see from the Trump administration’s plan to have the FDA fast-track new drugs.
  • Whether the Biologics Price Competition and Innovation Act will survive efforts to revise the Affordable Care Act — and what its impact would be on payer strategies to accelerate biosimilars.
  • How far PBMs will go with formulary exclusions as the “generic wave” tapers off and new high-cost specialty drugs come to market.
  • The success of continuing efforts to contain the soaring cost of specialty drugs.
  • The future of pharmacy network strategies like performance-based networks and value-based benefit designs.
  • Whether the new administration will ease regulations on drug importation, and if so how that will influence pharmacy benefit designs.
  • Trends in benefit design and copay data from AIS's Rx Benefit Data.
  • The impact of changes to the star ratings program on Medicare Part D.

    … and other business issues of great concern to plans, PBMs and pharma companies.

Renew your subscription today to continue receiving timely news and valuable business insights on managing pharmacy benefits. Your one-year subscription renewal includes:

  • 24 biweekly issues of timely news and insightful strategies for reducing costs and improving outcomes, delivered First Class by U.S. Mail and electronically (optional),
  • E-News Alerts whenever important news breaks, and
  • Access to your Subscriber Library, with:
    • Searchable archives of past articles,
    • Convenient library with PDFs of all issues since 2008,
    • Bonus Insight Reports, filled with practical advice on key areas of concern to today’s health care executives,
    • Recent stories of interest grouped for convenient reading, and
    • Regular postings from your editor.

Written By

Drug Benefit News is written by an editorial team with extensive experience in pharma/health care business publishing. Managing Editor Angela Maas has an extensive background in editing, reporting and writing for pharma publications. She also is the managing editor of AIS’s monthly newsletter Specialty Pharmacy News. Executive Editor Jill Brown is a veteran health care reporter who brings an intelligent perspective on the forces reshaping the health care industry.

Written For

  • Health plan managers
  • Purchasers, employers, pharmacy benefit companies
  • Managers in the pharmaceutical industry

AIS Guarantee

When you subscribe to Drug Benefit News, your satisfaction is fully guaranteed. If you are not completely satisfied with the newsletter within the first 30 days, just cancel and receive a prompt 100% refund.

Shipping Information

Electronic (PDF) versions of the newsletter are available, on the newsletter’s subscriber-only Web page, on the day of publication. Recipients should whitelist aisalert@aishealth.com to ensure delivery of the e-mail notification of new issues. Print newsletters are mailed 1st class through the U.S. Postal Service. You should receive your first issue within 5-7 business days of your order. A one-time $12 shipping and handling charge will be applied to your order.

Drug Benefit News

Renew Your Subscription Today!

Place your order through our secure shopping cart

24 issues, plus E-Alerts and access to a subscriber-only website
$651.00
48 issues, plus E-Alerts and access to a subscriber-only website
$1,172.00